NASDAQ
NRx Pharmaceuticals, Inc. (NRXP) has a free cash flow growth of -15.67% as of Friday, May 29, 2026. This represents a 59.20% increase compared to its 12-month average of -38.41%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.